Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies that
was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal …

Autoantibodies are abnormal antibodies which are generated by pathogenic B cells when
targeting an individual's own tissue. Autoantibodies have been identified as a symbol of …

The idiopathic inflammatory myopathies are characterized by muscle weakness, skin
disease and internal organ involvement. Autoimmunity is known to have a role in myositis …

Objectives To determine prevalence and co-existence of myositis specific autoantibodies
(MSAs) and myositis associated autoantibodies (MAAs) and associated clinical …

Autoantibodies specific for idiopathic inflammatory myopathy (myositis-specific
autoantibodies (MSAs)) are clinically useful biomarkers to help the diagnosis of …

The discovery of novel autoantigen systems related to idiopathic inflammatory myopathies
(collectively referred to as myositis) in adults and children has had major implications for the …

To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert
surveys, logistic regression, and conjoint analysis were used to develop 287 definitions …

Objective Myofiber necrosis without prominent inflammation is a nonspecific finding in
patients with dystrophies and toxic or immune‐mediated myopathies. However, the etiology …

Inflammatory myopathies are a group of acquired diseases, characterized by
immunoflogistic processes primarily involving the skeletal muscle. According to recent …

Objective To describe the clinical spectrum associated with aminoacyl-transfer RNA
synthetase (ARS) autoantibodies in patients with idiopathic inflammatory myositis defined …